Xanthium Sibiricum Fruit Extract

Xanthium Sibiricum Fruit Extract and pregnancy

Not Recommended

• Absorbed into the body
• Fetal development

Xanthium Sibiricum is a plant from the cocklebur family that contains bioactive compounds. While used in traditional medicine, it also contains toxic constituents including carboxyatractyloside, which can cause liver damage. In traditional Chinese medicine, Xanthium species are contraindicated during pregnancy due to concerns about potential toxicity. Toxicological studies have documented hepatotoxicity from oral consumption of Xanthium species. While topical absorption is generally lower than oral consumption, the presence of known toxic compounds and lack of pregnancy safety data is concerning. There are no studies confirming the safety of topical Xanthium extracts during pregnancy, and the potential for systemic absorption through skin, especially compromised skin barriers, presents theoretical risks to fetal development. Most herbalists and integrative medicine practitioners recommend avoiding Xanthium during pregnancy due to its traditional contraindication and known toxicity profile. Given safer alternatives exist for similar cosmetic benefits, pregnant women should choose products without this ingredient.

Xanthium Sibiricum Fruit Extract and breastfeeding

Not Recommended

• Passes into breast milk

Due to the hepatotoxic compounds present in Xanthium species and the theoretical risk of systemic absorption with topical use, there are concerns about potential transfer of these compounds into breast milk. Traditional medicine systems contraindicate Xanthium during lactation. While specific studies on topical use during breastfeeding are lacking, the known toxicity of the plant's constituents and absence of safety data warrant caution. Given the documented toxicity profile and lack of breastfeeding safety data, most healthcare practitioners recommend avoiding this ingredient while breastfeeding. Safer anti-inflammatory alternatives are widely available.

Xanthium Sibiricum Fruit Extract and postpartum

Safe to Use

For postpartum women not breastfeeding, the primary concern with Xanthium extract is the general hepatotoxicity documented with oral consumption. However, topical use typically involves minimal systemic absorption in healthy individuals with intact skin barriers. While the ingredient may provide anti-inflammatory benefits, the limited safety data and known toxicity profile suggest choosing better-studied alternatives. For postpartum skin concerns, many safer ingredients with more established efficacy are available.

Xanthium Sibiricum Fruit Extract and trying to conceive

Caution Advised

Given the traditional contraindication during pregnancy and the hepatotoxic profile of Xanthium species, women trying to conceive may want to discontinue use of products containing this extract as a precautionary measure before conception. While there is no specific evidence of fertility effects, the prudent approach is to avoid ingredients with pregnancy contraindications during the preconception period. The lack of safety data and known toxicity of the plant's constituents support this conservative recommendation.

Xanthium Sibiricum Fruit Extract and PCOS

Safe to Use

Xanthium Sibiricum extract has no known hormonal activity or effects on androgen levels relevant to PCOS. Its primary cosmetic benefit is anti-inflammatory activity. The anti-inflammatory properties could theoretically benefit inflammatory acne associated with PCOS. However, there is no specific research on this application, and safer, better-studied anti-inflammatory ingredients are available. Women with PCOS can use this ingredient topically with low concern for hormonal effects, though the limited safety data suggests preferring better-studied alternatives for similar benefits.

Xanthium Sibiricum Fruit Extract and general use

Safe to Use

Xanthium Sibiricum extract is used in cosmetics for its potential anti-inflammatory and antioxidant properties. In traditional Chinese medicine, it has been used topically for various skin conditions. The main concern is that the plant contains hepatotoxic compounds when consumed orally. Documented cases of liver toxicity exist from ingestion of Xanthium species. However, topical cosmetic use involves different exposure routes and typically much lower systemic absorption. There is limited specific safety data for cosmetic formulations. For the general public with healthy, intact skin, topical use in cosmetic concentrations is likely to have minimal risk given the limited absorption. However, those with compromised skin barriers, liver conditions, or sensitivity to botanical extracts should exercise caution. Better-studied alternatives may be preferable.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding
• Flagged in trying to conceive

Related ingredients

Ingredients suggested in place of Xanthium Sibiricum Fruit Extract, each one with its own page here.

• Allantoin
• Niacinamide
• Azelaic Acid

Ingredients that raise the same concerns.

• Cocamide MEAFetal development, Passes into breast milk, Absorbed into the body
• Benzophenone-4Fetal development, Passes into breast milk, Absorbed into the body
• Benzophenone-3Fetal development, Passes into breast milk, Absorbed into the body
• Arnica Montana Flower ExtractFetal development, Passes into breast milk, Absorbed into the body
• Anthemis Nobilis Flower OilFetal development, Passes into breast milk, Absorbed into the body
• ButylparabenFetal development, Passes into breast milk, Absorbed into the body

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.